PDCD1 and cancer: Among these proteins, programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) were the most studied ones, and the blocking antibodies of them have been approved to treat a wide variety of cancers [75, 76].